Thor Equities Group, a global leader in urban real estate development, leasing and management, announced today that it has executed a long term lease with PTC Therapeutics for 101,500 square feet at the New Jersey Center of Excellence.
Focused on the discovery and development of new medicines to treat rare disorders, PTC Therapeutics has signed a long term lease to occupy three floors at the Center of Excellence. Located in Bridgewater, New Jersey, The Center of Excellence campus totals nearly 800,000 square feet and caters to life science tenants with first-rate laboratory, research and development, and office buildings over 48 acres. Selected by the company for the campus’ unparalleled chemistry and biological research space in the heart of the New Jersey pharmaceutical corridor, the Center of Excellence is the ideal environment for PTC Therapeutics’.
“Thor Sciences has experienced unprecedented growth in the past few months and we are incredibly proud of our expanding platform,” said Chairman of Thor Equities, Joe Sitt. “We support PTC Therapeutics’ mission and are committed to helping them, as well as the other tenants at the Center of Excellence, to attract talent and build their team by offering first rate research and development space.”
“We are pleased to welcome PTC Therapeutics to the Center of Excellence and are thrilled with the amount of interest this trophy asset has attracted thus far. We believe they have selected the best location to execute their vision and are confident the innovative company will bring more vitality to the elite life sciences campus,” said COO of Thor Equities, Melissa Gliatta.
Thor Sciences recently acquired 95 Greene Street in Jersey City , the second research and development property for their growing life sciences division in the last nine months. With the addition of the eight story, 340,000 square foot office property, the platform exceeds 1 million square feet and continues to gain momentum. Thor plans to reposition the Jersey City property to meet demand from tenants in the life sciences, pharmaceuticals, green tech, ag-tech, healthcare, and medical fields. Thor previously acquired research and development properties in the San Francisco Bay Area and outside of Boston.
About Thor Equities: Thor Equities is a leader in the development, leasing and management of commercial, office, retail, hotel, residential, and mixed-use assets in premier urban locations worldwide. The company maximizes returns for investors by recognizing a property’s potential, reducing operating expenses, increasing tenant satisfaction, and leveraging market trends to maintain a long-term competitive edge. Thor Equities is also the exclusive representative of global retailers through Thor Retail Advisors, a premier leasing agent for marquee properties worldwide. For more information, visit www.thorequities.com.
